img

Global Severe Asthma Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Severe Asthma Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Severe Asthma Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Severe Asthma Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Children and Adults are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Severe Asthma Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Severe Asthma Treatment key manufacturers include Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma and Morphosys, etc. Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Severe Asthma Treatment can be divided into Oral, lnhaled, lntravenous and Subcutaneous, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Severe Asthma Treatment is widely used in various fields, such as Children, Adults and Teenagers,, etc. Children provides greatest supports to the Severe Asthma Treatment industry development. In 2022, global % sales of Severe Asthma Treatment went into Children filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Severe Asthma Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva Pharmaceutical
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Regeneron Pharmaceutical
4D Pharma plc
AB Pharma
Morphosys
Roche
Avalo Therapeutics
Suzhou Connect Biopharmaceuticals
Pieris Pharma
Biosion
Segment by Type
Oral
lnhaled
lntravenous
Subcutaneous

Segment by Application


Children
Adults
Teenagers

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Severe Asthma Treatment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Severe Asthma Treatment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Severe Asthma Treatment industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Severe Asthma Treatment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Severe Asthma Treatment introduction, etc. Severe Asthma Treatment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Severe Asthma Treatment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Severe Asthma Treatment Market Overview
1.1 Severe Asthma Treatment Product Overview
1.2 Severe Asthma Treatment Market Segment by Type
1.2.1 Oral
1.2.2 lnhaled
1.2.3 lntravenous
1.2.4 Subcutaneous
1.3 Global Severe Asthma Treatment Market Size by Type
1.3.1 Global Severe Asthma Treatment Market Size Overview by Type (2024-2034)
1.3.2 Global Severe Asthma Treatment Historic Market Size Review by Type (2024-2024)
1.3.3 Global Severe Asthma Treatment Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Severe Asthma Treatment Sales Breakdown by Type (2024-2024)
1.4.2 Europe Severe Asthma Treatment Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Severe Asthma Treatment Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Severe Asthma Treatment Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Severe Asthma Treatment Sales Breakdown by Type (2024-2024)
2 Global Severe Asthma Treatment Market Competition by Company
2.1 Global Top Players by Severe Asthma Treatment Sales (2024-2024)
2.2 Global Top Players by Severe Asthma Treatment Revenue (2024-2024)
2.3 Global Top Players by Severe Asthma Treatment Price (2024-2024)
2.4 Global Top Manufacturers Severe Asthma Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Severe Asthma Treatment Market Competitive Situation and Trends
2.5.1 Severe Asthma Treatment Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Severe Asthma Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Severe Asthma Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Severe Asthma Treatment Market
2.8 Key Manufacturers Severe Asthma Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Severe Asthma Treatment Status and Outlook by Region
3.1 Global Severe Asthma Treatment Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Severe Asthma Treatment Historic Market Size by Region
3.2.1 Global Severe Asthma Treatment Sales in Volume by Region (2024-2024)
3.2.2 Global Severe Asthma Treatment Sales in Value by Region (2024-2024)
3.2.3 Global Severe Asthma Treatment Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Severe Asthma Treatment Forecasted Market Size by Region
3.3.1 Global Severe Asthma Treatment Sales in Volume by Region (2024-2034)
3.3.2 Global Severe Asthma Treatment Sales in Value by Region (2024-2034)
3.3.3 Global Severe Asthma Treatment Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Severe Asthma Treatment by Application
4.1 Severe Asthma Treatment Market Segment by Application
4.1.1 Children
4.1.2 Adults
4.1.3 Teenagers
4.2 Global Severe Asthma Treatment Market Size by Application
4.2.1 Global Severe Asthma Treatment Market Size Overview by Application (2024-2034)
4.2.2 Global Severe Asthma Treatment Historic Market Size Review by Application (2024-2024)
4.2.3 Global Severe Asthma Treatment Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Severe Asthma Treatment Sales Breakdown by Application (2024-2024)
4.3.2 Europe Severe Asthma Treatment Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Severe Asthma Treatment Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Severe Asthma Treatment Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Severe Asthma Treatment Sales Breakdown by Application (2024-2024)
5 North America Severe Asthma Treatment by Country
5.1 North America Severe Asthma Treatment Historic Market Size by Country
5.1.1 North America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Severe Asthma Treatment Sales in Volume by Country (2024-2024)
5.1.3 North America Severe Asthma Treatment Sales in Value by Country (2024-2024)
5.2 North America Severe Asthma Treatment Forecasted Market Size by Country
5.2.1 North America Severe Asthma Treatment Sales in Volume by Country (2024-2034)
5.2.2 North America Severe Asthma Treatment Sales in Value by Country (2024-2034)
6 Europe Severe Asthma Treatment by Country
6.1 Europe Severe Asthma Treatment Historic Market Size by Country
6.1.1 Europe Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Severe Asthma Treatment Sales in Volume by Country (2024-2024)
6.1.3 Europe Severe Asthma Treatment Sales in Value by Country (2024-2024)
6.2 Europe Severe Asthma Treatment Forecasted Market Size by Country
6.2.1 Europe Severe Asthma Treatment Sales in Volume by Country (2024-2034)
6.2.2 Europe Severe Asthma Treatment Sales in Value by Country (2024-2034)
7 Asia-Pacific Severe Asthma Treatment by Region
7.1 Asia-Pacific Severe Asthma Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Severe Asthma Treatment Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Severe Asthma Treatment Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Severe Asthma Treatment Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Severe Asthma Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Severe Asthma Treatment Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Severe Asthma Treatment Sales in Value by Region (2024-2034)
8 Latin America Severe Asthma Treatment by Country
8.1 Latin America Severe Asthma Treatment Historic Market Size by Country
8.1.1 Latin America Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Severe Asthma Treatment Sales in Volume by Country (2024-2024)
8.1.3 Latin America Severe Asthma Treatment Sales in Value by Country (2024-2024)
8.2 Latin America Severe Asthma Treatment Forecasted Market Size by Country
8.2.1 Latin America Severe Asthma Treatment Sales in Volume by Country (2024-2034)
8.2.2 Latin America Severe Asthma Treatment Sales in Value by Country (2024-2034)
9 Middle East and Africa Severe Asthma Treatment by Country
9.1 Middle East and Africa Severe Asthma Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Severe Asthma Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Severe Asthma Treatment Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Severe Asthma Treatment Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Severe Asthma Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Severe Asthma Treatment Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Severe Asthma Treatment Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva Pharmaceutical
10.1.1 Teva Pharmaceutical Company Information
10.1.2 Teva Pharmaceutical Introduction and Business Overview
10.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Teva Pharmaceutical Severe Asthma Treatment Products Offered
10.1.5 Teva Pharmaceutical Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.2.4 AstraZeneca Severe Asthma Treatment Products Offered
10.2.5 AstraZeneca Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GlaxoSmithKline Severe Asthma Treatment Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Novartis Severe Asthma Treatment Products Offered
10.4.5 Novartis Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sanofi Severe Asthma Treatment Products Offered
10.5.5 Sanofi Recent Development
10.6 Regeneron Pharmaceutical
10.6.1 Regeneron Pharmaceutical Company Information
10.6.2 Regeneron Pharmaceutical Introduction and Business Overview
10.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Products Offered
10.6.5 Regeneron Pharmaceutical Recent Development
10.7 4D Pharma plc
10.7.1 4D Pharma plc Company Information
10.7.2 4D Pharma plc Introduction and Business Overview
10.7.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.7.4 4D Pharma plc Severe Asthma Treatment Products Offered
10.7.5 4D Pharma plc Recent Development
10.8 AB Pharma
10.8.1 AB Pharma Company Information
10.8.2 AB Pharma Introduction and Business Overview
10.8.3 AB Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.8.4 AB Pharma Severe Asthma Treatment Products Offered
10.8.5 AB Pharma Recent Development
10.9 Morphosys
10.9.1 Morphosys Company Information
10.9.2 Morphosys Introduction and Business Overview
10.9.3 Morphosys Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Morphosys Severe Asthma Treatment Products Offered
10.9.5 Morphosys Recent Development
10.10 Roche
10.10.1 Roche Company Information
10.10.2 Roche Introduction and Business Overview
10.10.3 Roche Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Roche Severe Asthma Treatment Products Offered
10.10.5 Roche Recent Development
10.11 Avalo Therapeutics
10.11.1 Avalo Therapeutics Company Information
10.11.2 Avalo Therapeutics Introduction and Business Overview
10.11.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Avalo Therapeutics Severe Asthma Treatment Products Offered
10.11.5 Avalo Therapeutics Recent Development
10.12 Suzhou Connect Biopharmaceuticals
10.12.1 Suzhou Connect Biopharmaceuticals Company Information
10.12.2 Suzhou Connect Biopharmaceuticals Introduction and Business Overview
10.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Products Offered
10.12.5 Suzhou Connect Biopharmaceuticals Recent Development
10.13 Pieris Pharma
10.13.1 Pieris Pharma Company Information
10.13.2 Pieris Pharma Introduction and Business Overview
10.13.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Pieris Pharma Severe Asthma Treatment Products Offered
10.13.5 Pieris Pharma Recent Development
10.14 Biosion
10.14.1 Biosion Company Information
10.14.2 Biosion Introduction and Business Overview
10.14.3 Biosion Severe Asthma Treatment Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Biosion Severe Asthma Treatment Products Offered
10.14.5 Biosion Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Severe Asthma Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Severe Asthma Treatment Industrial Chain Analysis
11.4 Severe Asthma Treatment Market Dynamics
11.4.1 Severe Asthma Treatment Industry Trends
11.4.2 Severe Asthma Treatment Market Drivers
11.4.3 Severe Asthma Treatment Market Challenges
11.4.4 Severe Asthma Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Severe Asthma Treatment Distributors
12.3 Severe Asthma Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of lnhaled
Table 3. Major Company of lntravenous
Table 4. Major Company of Subcutaneous
Table 5. Global Severe Asthma Treatment Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Severe Asthma Treatment Sales by Type (2024-2024) & (K Units)
Table 7. Global Severe Asthma Treatment Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Severe Asthma Treatment Sales by Type (2024-2024) & (US& Million)
Table 9. Global Severe Asthma Treatment Market Share in Value by Type (2024-2024)
Table 10. Global Severe Asthma Treatment Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Severe Asthma Treatment Sales by Type (2024-2034) & (K Units)
Table 12. Global Severe Asthma Treatment Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Severe Asthma Treatment Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Severe Asthma Treatment Sales Market Share in Value by Type (2024-2034)
Table 15. Global Severe Asthma Treatment Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Severe Asthma Treatment Sales by Type (2024-2024) & (K Units)
Table 17. North America Severe Asthma Treatment Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Severe Asthma Treatment Sales (K Units) by Type (2024-2024)
Table 19. Europe Severe Asthma Treatment Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Severe Asthma Treatment Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Severe Asthma Treatment Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Severe Asthma Treatment Sales (K Units) by Type (2024-2024)
Table 23. Latin America Severe Asthma Treatment Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Severe Asthma Treatment Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Severe Asthma Treatment Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Severe Asthma Treatment Sales by Company (2024-2024) & (K Units)
Table 27. Global Severe Asthma Treatment Sales Share by Company (2024-2024)
Table 28. Global Severe Asthma Treatment Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Severe Asthma Treatment Revenue Share by Company (2024-2024)
Table 30. Global Market Severe Asthma Treatment Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Severe Asthma Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Severe Asthma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Severe Asthma Treatment as of 2022)
Table 34. Date of Key Manufacturers Enter into Severe Asthma Treatment Market
Table 35. Key Manufacturers Severe Asthma Treatment Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Severe Asthma Treatment Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Severe Asthma Treatment Sales by Region (2024-2024) & (K Units)
Table 39. Global Severe Asthma Treatment Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Severe Asthma Treatment Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Severe Asthma Treatment Sales Market Share in Value by Region (2024-2024)
Table 42. Global Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Severe Asthma Treatment Sales by Region (2024-2034) & (K Units)
Table 44. Global Severe Asthma Treatment Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Severe Asthma Treatment Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Severe Asthma Treatment Sales Market Share in Value by Region (2024-2034)
Table 47. Global Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Severe Asthma Treatment Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Severe Asthma Treatment Sales by Application (2024-2024) & (K Units)
Table 50. Global Severe Asthma Treatment Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Severe Asthma Treatment Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Severe Asthma Treatment Sales Market Share in Value by Application (2024-2024)
Table 53. Global Severe Asthma Treatment Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Severe Asthma Treatment Sales by Application (2024-2034) & (K Units)
Table 55. Global Severe Asthma Treatment Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Severe Asthma Treatment Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Severe Asthma Treatment Sales Market Share in Value by Application (2024-2034)
Table 58. Global Severe Asthma Treatment Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Severe Asthma Treatment Sales by Application (2024-2024) (K Units)
Table 60. North America Severe Asthma Treatment Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Severe Asthma Treatment Sales by Application (2024-2024) (K Units)
Table 62. Europe Severe Asthma Treatment Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Severe Asthma Treatment Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Severe Asthma Treatment Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Severe Asthma Treatment Sales by Application (2024-2024) (K Units)
Table 66. Latin America Severe Asthma Treatment Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Severe Asthma Treatment Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Severe Asthma Treatment Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Severe Asthma Treatment Sales by Country (2024-2024) & (K Units)
Table 70. North America Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Severe Asthma Treatment Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Severe Asthma Treatment Sales Market Share in Value by Country (2024-2024)
Table 73. North America Severe Asthma Treatment Sales by Country (2024-2034) & (K Units)
Table 74. North America Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Severe Asthma Treatment Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Severe Asthma Treatment Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Severe Asthma Treatment Sales by Country (2024-2024) & (K Units)
Table 78. Europe Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Severe Asthma Treatment Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Severe Asthma Treatment Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Severe Asthma Treatment Sales by Country (2024-2034) & (K Units)
Table 82. Europe Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Severe Asthma Treatment Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Severe Asthma Treatment Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Severe Asthma Treatment Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Severe Asthma Treatment Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Severe Asthma Treatment Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Severe Asthma Treatment Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Severe Asthma Treatment Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Severe Asthma Treatment Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Severe Asthma Treatment Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Severe Asthma Treatment Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Severe Asthma Treatment Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Severe Asthma Treatment Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Severe Asthma Treatment Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Severe Asthma Treatment Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Severe Asthma Treatment Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Severe Asthma Treatment Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Severe Asthma Treatment Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Severe Asthma Treatment Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Severe Asthma Treatment Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Severe Asthma Treatment Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Severe Asthma Treatment Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Severe Asthma Treatment Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Severe Asthma Treatment Sales Market Share in Value by Country (2024-2034)
Table 109. Teva Pharmaceutical Company Information
Table 110. Teva Pharmaceutical Introduction and Business Overview
Table 111. Teva Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Teva Pharmaceutical Severe Asthma Treatment Product
Table 113. Teva Pharmaceutical Recent Development
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Introduction and Business Overview
Table 116. AstraZeneca Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. AstraZeneca Severe Asthma Treatment Product
Table 118. AstraZeneca Recent Development
Table 119. GlaxoSmithKline Company Information
Table 120. GlaxoSmithKline Introduction and Business Overview
Table 121. GlaxoSmithKline Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. GlaxoSmithKline Severe Asthma Treatment Product
Table 123. GlaxoSmithKline Recent Development
Table 124. Novartis Company Information
Table 125. Novartis Introduction and Business Overview
Table 126. Novartis Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. Novartis Severe Asthma Treatment Product
Table 128. Novartis Recent Development
Table 129. Sanofi Company Information
Table 130. Sanofi Introduction and Business Overview
Table 131. Sanofi Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Sanofi Severe Asthma Treatment Product
Table 133. Sanofi Recent Development
Table 134. Regeneron Pharmaceutical Company Information
Table 135. Regeneron Pharmaceutical Introduction and Business Overview
Table 136. Regeneron Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Regeneron Pharmaceutical Severe Asthma Treatment Product
Table 138. Regeneron Pharmaceutical Recent Development
Table 139. 4D Pharma plc Company Information
Table 140. 4D Pharma plc Introduction and Business Overview
Table 141. 4D Pharma plc Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. 4D Pharma plc Severe Asthma Treatment Product
Table 143. 4D Pharma plc Recent Development
Table 144. AB Pharma Company Information
Table 145. AB Pharma Introduction and Business Overview
Table 146. AB Pharma Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. AB Pharma Severe Asthma Treatment Product
Table 148. AB Pharma Recent Development
Table 149. Morphosys Company Information
Table 150. Morphosys Introduction and Business Overview
Table 151. Morphosys Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. Morphosys Severe Asthma Treatment Product
Table 153. Morphosys Recent Development
Table 154. Roche Company Information
Table 155. Roche Introduction and Business Overview
Table 156. Roche Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 157. Roche Severe Asthma Treatment Product
Table 158. Roche Recent Development
Table 159. Avalo Therapeutics Company Information
Table 160. Avalo Therapeutics Introduction and Business Overview
Table 161. Avalo Therapeutics Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 162. Avalo Therapeutics Severe Asthma Treatment Product
Table 163. Avalo Therapeutics Recent Development
Table 164. Suzhou Connect Biopharmaceuticals Company Information
Table 165. Suzhou Connect Biopharmaceuticals Introduction and Business Overview
Table 166. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 167. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product
Table 168. Suzhou Connect Biopharmaceuticals Recent Development
Table 169. Pieris Pharma Company Information
Table 170. Pieris Pharma Introduction and Business Overview
Table 171. Pieris Pharma Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 172. Pieris Pharma Severe Asthma Treatment Product
Table 173. Pieris Pharma Recent Development
Table 174. Biosion Company Information
Table 175. Biosion Introduction and Business Overview
Table 176. Biosion Severe Asthma Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 177. Biosion Severe Asthma Treatment Product
Table 178. Biosion Recent Development
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Severe Asthma Treatment Market Trends
Table 182. Severe Asthma Treatment Market Drivers
Table 183. Severe Asthma Treatment Market Challenges
Table 184. Severe Asthma Treatment Market Restraints
Table 185. Severe Asthma Treatment Distributors List
Table 186. Severe Asthma Treatment Downstream Customers
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Severe Asthma Treatment Product Picture
Figure 2. Global Severe Asthma Treatment Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Severe Asthma Treatment Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Severe Asthma Treatment Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of lnhaled
Figure 8. Global lnhaled Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of lntravenous
Figure 10. Global lntravenous Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Subcutaneous
Figure 12. Global Subcutaneous Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Severe Asthma Treatment Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Severe Asthma Treatment Sales Market Share by Type in 2022 & 2034
Figure 15. North America Severe Asthma Treatment Sales Market Share in Volume by Type in 2022
Figure 16. North America Severe Asthma Treatment Sales Market Share in Value by Type in 2022
Figure 17. Europe Severe Asthma Treatment Sales Market Share in Volume by Type in 2022
Figure 18. Europe Severe Asthma Treatment Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Severe Asthma Treatment Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Severe Asthma Treatment Sales Market Share in Value by Type in 2022
Figure 21. Latin America Severe Asthma Treatment Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Severe Asthma Treatment Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Severe Asthma Treatment Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Severe Asthma Treatment Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Severe Asthma Treatment Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Severe Asthma Treatment Revenue in 2022
Figure 27. Severe Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Children
Figure 29. Global Children Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Adults
Figure 31. Global Adults Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Teenagers
Figure 33. Global Teenagers Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Severe Asthma Treatment Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Severe Asthma Treatment Sales Market Share by Application in 2022 & 2034
Figure 36. North America Severe Asthma Treatment Sales Market Share in Volume by Application in 2022
Figure 37. North America Severe Asthma Treatment Sales Market Share in Value by Application in 2022
Figure 38. Europe Severe Asthma Treatment Sales Market Share in Volume by Application in 2022
Figure 39. Europe Severe Asthma Treatment Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Severe Asthma Treatment Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Severe Asthma Treatment Sales Market Share in Value by Application in 2022
Figure 42. Latin America Severe Asthma Treatment Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Severe Asthma Treatment Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Severe Asthma Treatment Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Severe Asthma Treatment Manufacturing Cost Structure
Figure 47. Severe Asthma Treatment Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries